All In MedTech

FDA Clearance Tracker · P140003-S125

Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 23, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P140003-S125
Device name
Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LD
Applicant
Abiomed, Inc.
Applicant location
Danvers, MA
Received
Mar 27, 2025
Decided
Jun 23, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P140003

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code OZD

FDA's approval statement

As written in FDA's record.

approval for a change to the Automated Impella Controller (AIC) battery pack cells and gas gauge integrated circuit

Source documents

Other decisions for Abiomed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.